List of Tables
    Table 1. Biopharmaceutical and Vaccine Production Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Biopharmaceutical and Vaccine Production Market Trends
    Table 3. Biopharmaceutical and Vaccine Production Market Drivers
    Table 4. Biopharmaceutical and Vaccine Production Market Challenges
    Table 5. Biopharmaceutical and Vaccine Production Market Restraints
    Table 6. Global Biopharmaceutical and Vaccine Production Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Biopharmaceutical and Vaccine Production Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Biopharmaceutical and Vaccine Production Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Biopharmaceutical and Vaccine Production Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Biopharmaceutical and Vaccine Production Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Biopharmaceutical and Vaccine Production Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Biopharmaceutical and Vaccine Production Revenue Share by Player, 2017-2022
    Table 13. Global Biopharmaceutical and Vaccine Production Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Biopharmaceutical and Vaccine Production by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical and Vaccine Production as of 2021)
    Table 15. Top Players of Biopharmaceutical and Vaccine Production in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Biopharmaceutical and Vaccine Production Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Biopharmaceutical and Vaccine Production Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Biopharmaceutical and Vaccine Production Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Biopharmaceutical and Vaccine Production Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Biopharmaceutical and Vaccine Production Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Biopharmaceutical and Vaccine Production Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Biopharmaceutical and Vaccine Production Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Biopharmaceutical and Vaccine Production Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Biopharmaceutical and Vaccine Production Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Biopharmaceutical and Vaccine Production Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Biopharmaceutical and Vaccine Production Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Biopharmaceutical and Vaccine Production Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Biopharmaceutical and Vaccine Production Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Novartis Company Details
    Table 31. Novartis Business Overview
    Table 32. Novartis Biopharmaceutical and Vaccine Production Product
    Table 33. Novartis Revenue in Biopharmaceutical and Vaccine Production Business (2017-2022) & (US$ Million)
    Table 34. Novartis Recent Development
    Table 35. Pfizer Company Details
    Table 36. Pfizer Business Overview
    Table 37. Pfizer Biopharmaceutical and Vaccine Production Product
    Table 38. Pfizer Revenue in Biopharmaceutical and Vaccine Production Business (2017-2022) & (US$ Million)
    Table 39. Pfizer Recent Development
    Table 40. Sanofi Company Details
    Table 41. Sanofi Business Overview
    Table 42. Sanofi Biopharmaceutical and Vaccine Production Product
    Table 43. Sanofi Revenue in Biopharmaceutical and Vaccine Production Business (2017-2022) & (US$ Million)
    Table 44. Sanofi Recent Development
    Table 45. Roche Company Details
    Table 46. Roche Business Overview
    Table 47. Roche Biopharmaceutical and Vaccine Production Product
    Table 48. Roche Revenue in Biopharmaceutical and Vaccine Production Business (2017-2022) & (US$ Million)
    Table 49. Roche Recent Development
    Table 50. Abbott Company Details
    Table 51. Abbott Business Overview
    Table 52. Abbott Biopharmaceutical and Vaccine Production Product
    Table 53. Abbott Revenue in Biopharmaceutical and Vaccine Production Business (2017-2022) & (US$ Million)
    Table 54. Abbott Recent Development
    Table 55. Regeneron Pharmaceuticals Company Details
    Table 56. Regeneron Pharmaceuticals Business Overview
    Table 57. Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Product
    Table 58. Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2017-2022) & (US$ Million)
    Table 59. Regeneron Pharmaceuticals Recent Development
    Table 60. Alexion Pharmaceuticals Company Details
    Table 61. Alexion Pharmaceuticals Business Overview
    Table 62. Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Product
    Table 63. Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccine Production Business (2017-2022) & (US$ Million)
    Table 64. Alexion Pharmaceuticals Recent Development
    Table 65. Johnson and Johnson Company Details
    Table 66. Johnson and Johnson Business Overview
    Table 67. Johnson and Johnson Biopharmaceutical and Vaccine Production Product
    Table 68. Johnson and Johnson Revenue in Biopharmaceutical and Vaccine Production Business (2017-2022) & (US$ Million)
    Table 69. Johnson and Johnson Recent Development
    Table 70. GlaxoSmithKline Company Details
    Table 71. GlaxoSmithKline Business Overview
    Table 72. GlaxoSmithKline Biopharmaceutical and Vaccine Production Product
    Table 73. GlaxoSmithKline Revenue in Biopharmaceutical and Vaccine Production Business (2017-2022) & (US$ Million)
    Table 74. GlaxoSmithKline Recent Development
    Table 75. Merck Company Details
    Table 76. Merck Business Overview
    Table 77. Merck Biopharmaceutical and Vaccine Production Product
    Table 78. Merck Revenue in Biopharmaceutical and Vaccine Production Business (2017-2022) & (US$ Million)
    Table 79. Merck Recent Development
    Table 80. Lonza Company Details
    Table 81. Lonza Business Overview
    Table 82. Lonza Biopharmaceutical and Vaccine Production Product
    Table 83. Lonza Revenue in Biopharmaceutical and Vaccine Production Business (2017-2022) & (US$ Million)
    Table 84. Lonza Recent Development
    Table 85. FUJIFILM Diosynth Biotechnologies Company Details
    Table 86. FUJIFILM Diosynth Biotechnologies Business Overview
    Table 87. FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Product
    Table 88. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical and Vaccine Production Business (2017-2022) & (US$ Million)
    Table 89. FUJIFILM Diosynth Biotechnologies Recent Development
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Biopharmaceutical and Vaccine Production Product Picture
    Figure 2. Global Biopharmaceutical and Vaccine Production Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Biopharmaceutical and Vaccine Production Market Size 2017-2028 (US$ Million)
    Figure 4. United States Biopharmaceutical and Vaccine Production Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Biopharmaceutical and Vaccine Production Market Size 2017-2028 (US$ Million)
    Figure 6. United States Biopharmaceutical and Vaccine Production Market Share in Global 2017-2028
    Figure 7. Biopharmaceutical and Vaccine Production Report Years Considered
    Figure 8. Product Picture of Biopharmaceutical
    Figure 9. Product Picture of Vaccine Production
    Figure 10. Global Biopharmaceutical and Vaccine Production Market Share by Type in 2022 & 2028
    Figure 11. Global Biopharmaceutical and Vaccine Production Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Biopharmaceutical and Vaccine Production Market Share by Type (2017-2028)
    Figure 13. United States Biopharmaceutical and Vaccine Production Market Share by Type in 2022 & 2028
    Figure 14. United States Biopharmaceutical and Vaccine Production Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Biopharmaceutical and Vaccine Production Market Share by Type (2017-2028)
    Figure 16. Product Picture of Pharmaceutical
    Figure 17. Product Picture of Biotechnology
    Figure 18. Product Picture of Academic and Research Institutes
    Figure 19. Product Picture of Others
    Figure 20. Global Biopharmaceutical and Vaccine Production Market Share by Application in 2022 & 2028
    Figure 21. Global Biopharmaceutical and Vaccine Production Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Biopharmaceutical and Vaccine Production Market Share by Application (2017-2028)
    Figure 23. United States Biopharmaceutical and Vaccine Production Market Share by Application in 2022 & 2028
    Figure 24. United States Biopharmaceutical and Vaccine Production Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Biopharmaceutical and Vaccine Production Market Share by Application (2017-2028)
    Figure 26. North America Biopharmaceutical and Vaccine Production Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Biopharmaceutical and Vaccine Production Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Biopharmaceutical and Vaccine Production Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Taiwan Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Philippines Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Biopharmaceutical and Vaccine Production Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Biopharmaceutical and Vaccine Production Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.A.E Biopharmaceutical and Vaccine Production Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Novartis Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2017-2022)
    Figure 55. Pfizer Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2017-2022)
    Figure 56. Sanofi Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2017-2022)
    Figure 57. Roche Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2017-2022)
    Figure 58. Abbott Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2017-2022)
    Figure 59. Regeneron Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2017-2022)
    Figure 60. Alexion Pharmaceuticals Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2017-2022)
    Figure 61. Johnson and Johnson Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2017-2022)
    Figure 62. GlaxoSmithKline Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2017-2022)
    Figure 63. Merck Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2017-2022)
    Figure 64. Lonza Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2017-2022)
    Figure 65. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical and Vaccine Production Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed